Mobile health (mHealth) can be so much more than smartphone apps, and it is a growing movement in the United States that can empower patients, providers, and payers, according to Meg Maley, RN, BSN, founder and CEO of CanSurround.
%jwplayer%
Mobile health (mHealth) can be so much more than smartphone apps, and it is a growing movement in the United States that can empower patients, providers, and payers, according to Meg Maley, RN, BSN, founder and CEO of CanSurround.
Ms Maley explained that for many cancer patients, the experience of their cancer journey is singular to them, regardless of the fact that many people have walked the path before. They can easily become overwhelmed and mHealth can be part of the solution.
mHealth technology doesn’t just compile data for the sake it doing so, but data that is personalized and can be analyzed and served back to the patient, provider, and case manager.
“Data is transformed into knowledge that has the power to influence actions and outcomes,” she explained.
Ms Maley also discussed applications that help guide patients and explained how CanSurround focused on reducing distress and creating emotional well-being for cancer patients.
“Instead of tracking people’s exercise patterns or nutrition, we’re tracking their mood, we’re tracking their distress, we’re tracking their emotional state, and then pushing them information, articles, etc., that corresponds to where they are emotionally on their journey,” she said.
Exploring Racial, Ethnic Disparities in Cancer Care Prior Authorization Decisions
October 24th 2024On this episode of Managed Care Cast, we're talking with the author of a study published in the October 2024 issue of The American Journal of Managed Care® that explored prior authorization decisions in cancer care by race and ethnicity for commercially insured patients.
Listen
NCCN Data Find Racial, Socioeconomic Disparities in Quality of Care for Metastatic Pancreatic Cancer
April 9th 2025New data from the National Comprehensive Cancer Network (NCCN) reveal that socially vulnerable and minority patients with metastatic pancreatic cancer are less likely to receive recommended treatments and achieve longer survival.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen